On the other hand, it was shown that the expression of CD9 was downregulated in most solid tumors, including CRC, and that decreased expression of CD9 strongly correlated with the progression, increased risk of recurrence, angiogenesis, and metastasis [50]. Here, CD9 is linked to colorectal carcinoma.